PharmaShots | Incisive News in 3 Shots

Subscribe Now

Epithelioid Sarcoma

Epizyme's Tazverik (tazemetostat) Receives the US FDA's Accelerated Approval as the First Therapy for Epithelioid Sarcoma

Epizyme's Tazverik (tazemetostat) Receives the US FDA's Accelerated Approval as the First Therapy for Epithelioid Sarcoma

January 24, 2020

Epizyme Reports FDA's Acceptance of NDA for Tazemetostat to Treat Epithelioid Sarcoma

Epizyme Reports FDA's Acceptance of NDA for Tazemetostat to Treat Epithelioid Sarcoma

July 26, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us